Literature DB >> 21616711

High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases.

Cristiane M Thomazini1, Danielle A G Samegima, Maria A M Rodrigues, Carlos R Victoria, Josias Rodrigues.   

Abstract

The intestinal population of Escherichia coli is increased in patients with inflammatory bowel disease (IBD), but the reason for this elevation, the particular features of these bacteria and their potential role in the pathogenesis of the disease are not known. The present study was undertaken to investigate the adherence abilities and some virulence properties of a collection of 131 E. coli isolates cultured from rectal biopsies of 23 subjects diagnosed with ulcerative colitis (UC), 8 with Crohn's disease (CD) and 23 control patients from southern Brazil. The adherence abilities of the bacteria were investigated in vitro, using HEp-2 epithelial cells in assays of 3 and 6h of bacteria-cell contact. The isolates were screened by PCR with primers for the following virulence genetic markers: plasmid of aggregative adhesion (pAA) and the aggregative adherence fimbriae R (aggR), E. coli attaching and effacing (eae), invasion-associated locus (ial), invasion plasmid antigen H (ipaH) and Shiga citotoxin-encoding (stx) genes. HEp-2 cells aggregative adherent E. coli strains, as detected in the 3h adherence assay, were found in 14/23 (60.9%) patients with UC, 7/8 (87.5%) with CD and in 7/23 (30.4%) controls (p=0.011). Virulence genetic markers were detected in strains of 9 patients with UC (39.1%), but in none of CD or control group. Two of these UC patients had strains harboring both pAA and aggR, one had strains positive for aggR, four had strains positive for eae and two had strains positive for stx. These results suggest that the augmented population of E. coli on the rectal mucosa of IBD patients, particularly of those diagnosed with UC, is mostly comprised of aggregative adherent strains, some of which possessing classical virulence markers of E. coli.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21616711     DOI: 10.1016/j.ijmm.2011.04.015

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  26 in total

Review 1.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

2.  Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway.

Authors:  Erik J Boll; Carsten Struve; Anja Sander; Zachary Demma; Karen A Krogfelt; Beth A McCormick
Journal:  Cell Microbiol       Date:  2011-10-27       Impact factor: 3.715

Review 3.  Epidemiology and clinical manifestations of enteroaggregative Escherichia coli.

Authors:  Betina Hebbelstrup Jensen; Katharina E P Olsen; Carsten Struve; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

4.  Early life establishment of site-specific microbial communities in the gut.

Authors:  Joann Romano-Keeler; Daniel J Moore; Chunlin Wang; Robert M Brucker; Christopher Fonnesbeck; James C Slaughter; Haijing Li; Danielle P Curran; Shufang Meng; Hernan Correa; Harold N Lovvorn; Yi-Wei Tang; Seth Bordenstein; Alfred L George; Jörn-Hendrik Weitkamp
Journal:  Gut Microbes       Date:  2014-03-05

Review 5.  Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity.

Authors:  Margarita Martinez-Medina; Librado Jesus Garcia-Gil
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 6.  Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.

Authors:  Daisy Jonkers; John Penders; Ad Masclee; Marieke Pierik
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

7.  Adhesion of marine cryptic Escherichia isolates to human intestinal epithelial cells.

Authors:  Carla Vignaroli; Laura Di Sante; Gloria Magi; Gian Marco Luna; Andrea Di Cesare; Sonia Pasquaroli; Bruna Facinelli; Francesca Biavasco
Journal:  ISME J       Date:  2014-09-12       Impact factor: 10.302

8.  NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells.

Authors:  Anna Negroni; Eleonora Colantoni; Roberta Vitali; Francesca Palone; Maria Pierdomenico; Manuela Costanzo; Vincenzo Cesi; Salvatore Cucchiara; Laura Stronati
Journal:  Inflamm Res       Date:  2016-06-22       Impact factor: 4.575

Review 9.  Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.

Authors:  Rok Orel; Tina Kamhi Trop
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

10.  Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis.

Authors:  Angélica Cruz-Lebrón; Leticia D'argenio Garcia; Aarthi Talla; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Rafick-Pierre Sékaly; Karina Inacio Ladislau de Carvalho; Alan D Levine
Journal:  J Crohns Colitis       Date:  2020-07-09       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.